U-Neuron Biomedical (ROCO:6973) Net Margin % : -191.85% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. U-Neuron Biomedical's Net Income for the six months ended in Dec. 2023 was NT$-28.82 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil. Therefore, U-Neuron Biomedical's net margin for the quarter that ended in Dec. 2023 was -191.85%.

The historical rank and industry rank for U-Neuron Biomedical's Net Margin % or its related term are showing as below:

ROCO:6973' s Net Margin % Range Over the Past 10 Years
Min: -314.14 Med: -161.15 Max: -39.62
Current: -314.14

ROCO:6973's Net Margin % is ranked worse than
58.79% of 1029 companies
in the Biotechnology industry
Industry Median: -154.15 vs ROCO:6973: -314.14

U-Neuron Biomedical Net Margin % Historical Data

The historical data trend for U-Neuron Biomedical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Net Margin % Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Margin %

-39.62

-161.15

-314.14

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	-	-111.56	-226.65	-467.24	-191.85

Competitive Comparison of U-Neuron Biomedical's Net Margin %

For the Biotechnology subindustry, U-Neuron Biomedical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Net Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Net Margin % falls into.

U-Neuron Biomedical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-84.891	/	27.023
	=	-314.14 %

U-Neuron Biomedical's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-28.822	/	15.023
	=	-191.85 %

U-Neuron Biomedical (ROCO:6973) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

U-Neuron Biomedical Net Margin % Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines